Cargando…
Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices
Growth differentiation factor (GDF)-15 inhibits platelet activation, prevents thrombus formation, and has been linked to bleeding events. This was a prospective study including 51 left-ventricular assist device (LVAD) patients on aspirin and phenprocoumon. Platelet surface expression of activated gl...
Autores principales: | Tscharre, Maximilian, Wittmann, Franziska, Kitzmantl, Daniela, Lee, Silvia, Eichelberger, Beate, Wadowski, Patricia P., Laufer, Günther, Wiedemann, Dominik, Panzer, Simon, Perkmann, Thomas, Zimpfer, Daniel, Gremmel, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031879/ https://www.ncbi.nlm.nih.gov/pubmed/35455481 http://dx.doi.org/10.3390/ph15040484 |
Ejemplares similares
-
Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome
por: Mutschlechner, David, et al.
Publicado: (2023) -
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
por: Tscharre, Maximilian, et al.
Publicado: (2020) -
Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes
por: Wadowski, Patricia P., et al.
Publicado: (2020) -
Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y(12) inhibitors
por: Wadowski, Patricia P., et al.
Publicado: (2019) -
Protease‐activated receptor‐mediated platelet aggregation in patients with type 2 diabetes on potent P2Y
(12) inhibitors
por: Panzer, Benjamin, et al.
Publicado: (2022)